Both medications are excellent for managing blood sugar if you have diabetes, but tirzepatides dual receptor activation may offer added benefits for glucose control alongside weight loss
As the body adapts and metabolism stabilizes, sleep quality often improves
It adds empty calories that work against weight loss goals
Mazdutide: GLP-1 + Glucagon Mazdutide (IBI362) is developed by Innovent Biologics in partnership with Eli Lilly
Evaluation of intact proinsulin levels reveals significant decreases with tirzepatide at 5, 10, and 15 mg doses, indicating potential positive changes in insulin processing.Furthermore, tirzepatide therapy dramatically lowers glucose-adjusted glucagon levels, emphasizing improvements in glucose regulation, beta-cell activity, insulin processing, and reduced glucagon levels [74]